Clavicular Shortening Post-fracture - Does it Change? - a Prospective Study of 70 Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02089282 |
Recruitment Status : Unknown
Verified March 2014 by Holbaek Sygehus.
Recruitment status was: Recruiting
First Posted : March 17, 2014
Last Update Posted : March 17, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Stability of Clavicular Fractures Within the First 3 Weeks | Device: Ultrasound |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 70 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 21 Days |
Study Start Date : | March 2014 |
Estimated Primary Completion Date : | August 2014 |
Group/Cohort | Intervention/treatment |
---|---|
Clavicle fractures |
Device: Ultrasound |
- Change in clavicular length [ Time Frame: 3 weeks ]The dynamic testing of clavicular length and when or which fracures that are stabile.
- Oxford shoulder score [ Time Frame: 21 days ]
- Constant score [ Time Frame: 21 days ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 17 Years to 90 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
All patients who sustain a displaced medial, mid and lateral clavicle fracture from March 2014 to August 2015 referred from Slagelse and Holbæk emergency departments are eligible. The last patients are seen end of mid-July 2015 given the 21 days of follow up.
Exclusion Criteria:
Patients that have bilateral clavicle fractures and/or prior operations involving the clavicle are excluded. Malignant diagnoses are excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02089282
Denmark | |
Holbæk sygehus | Recruiting |
Holbæk, Vest-sjælland, Denmark, 4300 | |
Contact: Anders Thorsmark Høj, MD + 45 5948000 | |
Contact: Anders Thorsmark Høj, MD +45 59484000 athh@regionsjaelland.dk | |
Principal Investigator: Anders Thorsmark Høj, MD |
Responsible Party: | Holbaek Sygehus |
ClinicalTrials.gov Identifier: | NCT02089282 |
Other Study ID Numbers: |
SJ-369 |
First Posted: | March 17, 2014 Key Record Dates |
Last Update Posted: | March 17, 2014 |
Last Verified: | March 2014 |
Fractures, Bone Wounds and Injuries |